ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Corindus Vascular Robotics Inc

Corindus Vascular Robotics Inc (CVRS)

4.27
0.00
(0.00%)
Closed December 28 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.27
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
4.27
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CVRS Latest News

Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers

At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the...

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference

Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote treatment Corindus Vascular Robotics, Inc...

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology Corindus Vascular Robotics, Inc. (“Corindus” or the...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc. PR Newswire NEW YORK, Aug. 8, 2019 NEW YORK, Aug. 8, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Corindus Reports Second Quarter 2019 Results

Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an all-cash transaction Second quarter revenue of...

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

-- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion -- Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of...

Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, and David...

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release second quarter 2019 financial and business results...

Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities

One of the nation’s largest hospital networks adopts vascular robotic technology in multiple hospital locations to treat patients in need of cardiovascular care Corindus Vascular Robotics, Inc...

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CVRS - Frequently Asked Questions (FAQ)

What is the current Corindus Vascular Robotics share price?
The current share price of Corindus Vascular Robotics is US$ 4.27
What is the 1 year trading range for Corindus Vascular Robotics share price?
Corindus Vascular Robotics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GRFXGraphex Group Limited
US$ 0.435
(52.33%)
9.1M
WWRWestwater Resources Inc
US$ 0.85
(46.55%)
8.04M
RYDERyde Group Ltd
US$ 0.6298
(42.81%)
5.98M
AMBOAmbow Education Holding Ltd
US$ 3.09
(37.95%)
6.54M
BURUNuburu Inc
US$ 0.5857
(32.21%)
10.04M
USEUSCF Energy Commodity Strategy Absolute Return Fund
US$ 27.40
(-27.89%)
2.17k
ROLRHigh Roller Technologies Inc
US$ 4.02
(-21.02%)
53.43k
MMAMixed Martial Arts Group Limited
US$ 1.441
(-17.66%)
141.62k
CPHIChina Pharma Holdings Inc
US$ 0.176
(-15.79%)
2.51M
HTUSCapitol Series Trust
US$ 38.80
(-15.15%)
63.74k
UVIX2x Long VIX Futures ETF
US$ 3.215
(8.25%)
91.49M
OPTTOcean Power Technologies Inc
US$ 0.4711
(3.97%)
81.92M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.00
(3.27%)
81.61M
KULRKULR Technology Group Inc
US$ 4.66
(-2.92%)
77.49M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.195
(10.03%)
65.17M

Discussion

View Full Feed
CherryTree1 CherryTree1 2 minutes ago
What NWBO trial failed?
They had one for prostate cancer that they never followed through on by know of none that failed.
NWBO
surfkast surfkast 2 minutes ago
[pre]

Financials lists the Income Statement, Balance Sheet and Cash Flow statements (annual and quaterly) reported.
Name BRL in Million except per share data

TTM
2023
2022
2021
2020
2019
2018
2017
2016
HMBL
Investor082 Investor082 2 minutes ago
The pumpers are already positioning the company for the following (post UK approval):

1) Revenue recognition from UK will be swift, particularly with support of $50M in additional financing available.

2) New combo trial endpoints will allow quick results.

NWBO
iclight iclight 2 minutes ago
Has nothing to do with what I said. But you don’t understand how drugs are approved so keep blabbering.
NWBO
WORTHWHILE WORTHWHILE 3 minutes ago
So little in the market and available.  I usually have an open bid @0.025, I did not get any.  Usually on drinks and drabs of small amounts from old shareholders cleaning out for tax reasons from now till end of year.  Maybe?
BWTX
Biotechotcguy Biotechotcguy 3 minutes ago
Garbage management end of story. 
BLPG
4C 4C 4 minutes ago
When the MM's lose interest here, it's done.

They've been toying with the spread for months.
UNVC
CherryTree1 CherryTree1 4 minutes ago
more than 20 weeks per my calculations . . . so does that even make sense.
Curve is a alleging this Big Money investor believed NWBO/DCVAX was going to be a Big success with the announcement and accumulated 100 million shares which was about $75 million at the time). Was there news 20 weeks (
NWBO
Biotechotcguy Biotechotcguy 4 minutes ago
Fam they already said commercialization starts in 2025. Their partner Aran R&D has also stated such (check their website and LinkedIn) Aran R&D doesn't play around they are heavy hitters in the medical tech space (just look at their portfolio and exits). Turn your phone off for a few months then che
DROR
delerious1 delerious1 4 minutes ago
OH .IS THAT RIGHT?
GVSI
dstock07734 dstock07734 5 minutes ago
Include IDO inhibitor as the possible booster too.
NWBO
lizzy241 lizzy241 5 minutes ago
Hey, Larry Bird Legend, aka LBL, are you the new San Diego dude??? Please reply if you're still involved. We need your input. Feel free to pop in to say Happy Holidays. Are you still connected to the old Connecticut crew?
AMRN
marcis marcis 6 minutes ago
After two sluggish years SIDU is coming to bear fruit



Just some satellite trivia

My father worked at RCA and made parts for the first communication satellite
He was a tool and die maker ( machinist)

1958
RCA launches first
SIDU
TrendTrade2016 TrendTrade2016 7 minutes ago
THE 20TH IS WHEN THE RUN WOULD START IF GEORGE GIVES THE MAKER IN CHARGE OF THE ORDER FLOW THE GO AHEAD
GVSI
Hardazoak Hardazoak 7 minutes ago
That is the view from aabb stockpile looking down where the aabb processing plant is. Just a skip and a hop away, as Benny said.
AABB
Mr. Dragon Mr. Dragon 7 minutes ago
Sanctioned
Providential Securities, Inc. (CRD
#31189, Fountain Valley,
California) and Henry Dack
Fahman (CRD #1952649,
Registered Principal, Huntington
Beach, California) submitted a
Letter of Acceptance, Waiver, and
Consent in which the firm
PHIL
3331 3331 8 minutes ago
Prove it - cut and paste the answer you claim I'm ignoring.

I asked for NEGATIVE aspects of the 25 bil shares, and you still have not provided any! Maybe you should ask Lifetime, JNdouble1, GetSeriousOK and ddls for help?" Maybe you five geniuses (NOT!) can come up with an answer, but
BIEL
Monksdream Monksdream 8 minutes ago
ARQQ, in this Barchart sector
https://www.barchart.com/stocks/quotes/ARQQ/competitors?quoteSectors=-ITSO&viewName=main&orderBy=weightedAlpha&orderDir=desc
ARQQ
sumbuysumsell sumbuysumsell 8 minutes ago
Totally agree with your thoughts….
And yet, a wise person once said to me that "anything and everything is for sale at the right price."
AVXL
cjstocksup cjstocksup 8 minutes ago
This is one of the Most Important Videos you will watch

American Farmer says he’s tested his soil and it has 5x the amount of aluminum it used to have. The GMO seeds grow fine, all his heirloom seed crops are all the sudden failing (shows proof)

Reminder, Bill Gates is
peterus peterus 9 minutes ago
monday big red day coming 

ILLR
Hardazoak Hardazoak 9 minutes ago
That is what bashers do, bring misleading information and fabricate lies. The only mission they have is for aabb holders to sell and potentially new investors to not buy.
AABB
delerious1 delerious1 10 minutes ago
With the latest shipments from the Fran mine supplying material to the Bishop Mill to fine-tune all the improvements that have been going on for the last few weeks in the Mill...to get recovered Gold etc as high as possible almost or already complete....

We all know that there is plen
NBRI

Your Recent History

Delayed Upgrade Clock